Total submissions: 9
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Genetic Services Laboratory, |
RCV000500420 | SCV000593710 | likely benign | not specified | 2017-02-07 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV000566132 | SCV000661149 | likely benign | Hereditary cancer-predisposing syndrome | 2018-06-22 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Color Diagnostics, |
RCV000566132 | SCV000911046 | benign | Hereditary cancer-predisposing syndrome | 2015-09-23 | criteria provided, single submitter | clinical testing | |
Invitae | RCV000917594 | SCV001062879 | benign | Hereditary breast ovarian cancer syndrome | 2023-05-04 | criteria provided, single submitter | clinical testing | |
Mendelics | RCV000989018 | SCV001139049 | likely benign | Breast-ovarian cancer, familial, susceptibility to, 2 | 2019-05-28 | criteria provided, single submitter | clinical testing | |
CHEO Genetics Diagnostic Laboratory, |
RCV001170461 | SCV001333041 | likely benign | Breast and/or ovarian cancer | 2021-06-29 | criteria provided, single submitter | clinical testing | |
Genetics Program, |
RCV000917594 | SCV002515261 | likely benign | Hereditary breast ovarian cancer syndrome | 2021-11-01 | criteria provided, single submitter | research | |
Sema4, |
RCV000566132 | SCV002533745 | benign | Hereditary cancer-predisposing syndrome | 2020-11-28 | criteria provided, single submitter | curation | |
Institute for Biomarker Research, |
RCV000917594 | SCV002819202 | benign | Hereditary breast ovarian cancer syndrome | 2022-09-27 | criteria provided, single submitter | clinical testing |